Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
September 19, 2017
Glenmark receives ANDA approval for Propafenone Hydrochloride Extended-Release Capsules USP, 225 mg, 325 mg, and 425 mg
September 11, 2017
Glenmark Pharmaceuticals Reports Positive Data in a Phase 2a Study of GBR 830 for the Treatment of Patients with Atopic Dermatitis
July 31, 2017
US Media Contact
For media inquiries only, please contact An Phan, Corporate Communications.
For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.